Schonfeld Strategic Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-523,008	Closed	-$2.11M	–	2097
2025 Q1	$2.11M	Buy	523,008 +476,111	+1,015%	+$1.59M	0.01%	942
2024 Q4	$150K	Buy	+46,897	New	+$159K	﹤0.01%	1801
2021 Q1	–	Sell	-2,000	Closed	-$53K	–	1836
2020 Q4	$53K	Buy	+2,000	New	+$50.6K	﹤0.01%	1491

Schonfeld Strategic Advisors's CKPT Position: Q2 2025 in Review

Schonfeld Strategic Advisors sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 523,008 shares — an estimated $2.11M sold.

Schonfeld Strategic Advisors first reported a position in CKPT in Q4 2020 and held it in 3 quarters. The position peaked at $2.11M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Schonfeld Strategic Advisors reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 523,008 Checkpoint Therapeutics shares in Q2 2025, an estimated $2.11M.
Schonfeld Strategic Advisors first reported a position in Checkpoint Therapeutics in Q4 2020 and held it in 3 quarters.
Schonfeld Strategic Advisors's Checkpoint Therapeutics position peaked at $2.11M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.